Search

Your search keyword '"Trinks, J."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Trinks, J." Remove constraint Author: "Trinks, J."
42 results on '"Trinks, J."'

Search Results

2. Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals

4. Clinical utility of pharmacogenomics in the management of hepatitis C

10. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent

13. SP-0645: Automated treatment planning at NKI: benefits and challenges

18. CSI-EPT: A novel contrast source approach to MRI based electric properties tomography and patient-specific SAR

23. Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?

24. Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotype.

25. Development of a nested real time PCR/high resolution melting assay for human T-cell lymphotropic viruses types 1 and 2 (HTLV-1 and 2) identification.

26. A Two-Time Point Analysis of Gut Microbiota in the General Population of Buenos Aires and Its Variation Due to Preventive and Compulsory Social Isolation During the COVID-19 Pandemic.

27. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype.

28. Genetic diversity and phylogeographic analysis of human herpesvirus type 8 (HHV-8) in two distant regions of Argentina: Association with the genetic ancestry of the population.

29. The genetic variability of hepatitis B virus subgenotype F1b precore/core gene is related to the outcome of the acute infection.

30. Unexpected high seroprevalence of hepatitis E virus in patients with alcohol-related cirrhosis.

31. Prevalence and Factors Related to Natural Resistance-Associated Substitutions to Direct-Acting Antivirals in Patients with Genotype 1 Hepatitis C Virus Infection.

32. Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C.

33. Role of HLA-DP and HLA-DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population.

34. Increased prevalence of human herpesvirus type 8 (HHV-8) genome among blood donors from North-Western Argentina.

35. Hepatitis C virus resistance to the new direct-acting antivirals.

36. CSI-EPT: A Contrast Source Inversion Approach for Improved MRI-Based Electric Properties Tomography.

37. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations.

38. Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3.

39. Human pegivirus molecular epidemiology in Argentina: potential contribution of Latin American migration to genotype 3 circulation.

40. In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes.

41. Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina.

42. Detection of hepatitis B virus (HBV) genotype E carried--even in the presence of high titers of anti-HBs antibodies--by an Argentinean patient of African descent who had received vaccination against HBV.

Catalog

Books, media, physical & digital resources